![]() | This article contains promotional content .(January 2024) |
Ravgen Inc. is a privately owned biotech company founded in 2000 by Chairman and C.E.O. Dr. Ravinder Dhallan. [1] Ravgen Inc. performs research in the prenatal diagnostic field and has developed non-invasive prenatal diagnosis testing for Down Syndrome. [2]
Ravgen has published peer-reviewed articles on genetic research in publications such as the Journal of the American Medical Association in 2004, [3] The Lancet in 2007, [4] and the New England Journal of Medicine in 2012. [5] In addition, Ravgen has received some acclaim from its research on non-invasive prenatal DNA testing. [6]